| Year |
Citation |
Score |
| 2024 |
Madarati H, DeYoung V, Singh K, Sparring T, Kwong AC, Fredenburgh JC, Teney C, Koschinsky ML, Boffa MB, Weitz JI, Kretz CA. Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13. Scientific Reports. 14: 9073. PMID 38643218 DOI: 10.1038/s41598-024-59672-6 |
0.314 |
|
| 2022 |
Doerfler AM, Park SH, Assini JM, Youssef A, Saxena L, Yaseen AB, De Giorgi M, Chuecos M, Hurley AE, Li A, Marcovina SM, Bao G, Boffa MB, Koschinsky ML, Lagor WR. disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study. Molecular Therapy. Methods & Clinical Development. 27: 337-351. PMID 36381302 DOI: 10.1016/j.omtm.2022.10.009 |
0.314 |
|
| 2022 |
Koschinsky ML, Boffa MB. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology. Atherosclerosis. 349: 92-100. PMID 35606081 DOI: 10.1016/j.atherosclerosis.2022.04.001 |
0.335 |
|
| 2022 |
Clark JR, Gemin M, Youssef A, Marcovina SM, Prat A, Seidah NG, Hegele RA, Boffa MB, Koschinsky ML. Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a). Journal of Lipid Research. 100216. PMID 35469919 DOI: 10.1016/j.jlr.2022.100216 |
0.362 |
|
| 2020 |
Gonen A, Yang X, Yeang C, Alekseeva E, Koschinsky M, Witztum JL, Boffa MB, Tsimikas S. Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein(a). Journal of Lipid Research. PMID 32641432 DOI: 10.1194/Jlr.Ra120000830 |
0.346 |
|
| 2018 |
Romagnuolo R, DeMarco K, Scipione CA, Boffa MB, Koschinsky ML. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells. Thrombosis Research. 169: 1-7. PMID 29990619 DOI: 10.1016/j.thromres.2018.07.002 |
0.311 |
|
| 2017 |
Romagnuolo R, Scipione CA, Marcovina SM, Gemin M, Seidah NG, Boffa MB, Koschinsky ML. Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9. Plos One. 12: e0180869. PMID 28750079 DOI: 10.1371/Journal.Pone.0180869 |
0.323 |
|
| 2017 |
Scipione CA, McAiney JT, Simard DJ, Bazzi ZA, Gemin M, Romagnuolo R, Macrae FL, Ariëns RA, Hegele RA, Auld J, Gauld JW, Boffa MB, Koschinsky ML. Characterization of the I4399M variant of apolipoprotein(a): Implications for altered prothrombotic properties of lipoprotein(a). Journal of Thrombosis and Haemostasis : Jth. PMID 28632940 DOI: 10.1111/Jth.13759 |
0.314 |
|
| 2015 |
Romagnuolo R, Scipione CA, Boffa MB, Marcovina SM, Seidah NG, Koschinsky ML. Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor. The Journal of Biological Chemistry. 290: 11649-62. PMID 25778403 DOI: 10.1074/Jbc.M114.611988 |
0.301 |
|
| 2014 |
Romagnuolo R, Marcovina SM, Boffa MB, Koschinsky ML. Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a). Journal of Lipid Research. 55: 625-34. PMID 24478033 DOI: 10.1194/jlr.M036566 |
0.37 |
|
| 2013 |
Leibundgut G, Scipione C, Yin H, Schneider M, Boffa MB, Green S, Yang X, Dennis E, Witztum JL, Koschinsky ML, Tsimikas S. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). Journal of Lipid Research. 54: 2815-30. PMID 23828779 DOI: 10.1194/Jlr.M040733 |
0.347 |
|
| 2013 |
Liu L, Boffa MB, Koschinsky ML. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system. Plos One. 8: e52287. PMID 23326327 DOI: 10.1371/journal.pone.0052287 |
0.368 |
|
| 2012 |
Garand M, Lin JH, Hill CE, Zagorac B, Koschinsky ML, Boffa MB. Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site. Cytokine. 57: 389-97. PMID 22217421 DOI: 10.1016/j.cyto.2011.11.023 |
0.323 |
|
| 2011 |
Romagnuolo R, Boffa MB, Koschinsky ML. Apolipoprotein(a)-Dependent Inhibition of Pericellular Plasminogen Activation Is Mediated by Specific Cellular Receptors Blood. 118: 2236-2236. DOI: 10.1182/BLOOD.V118.21.2236.2236 |
0.338 |
|
| 2009 |
Liu L, Craig AW, Meldrum HD, Marcovina SM, Elliott BE, Koschinsky ML. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3. The Biochemical Journal. 418: 325-36. PMID 18821851 DOI: 10.1042/Bj20080744 |
0.419 |
|
| 2008 |
Feric NT, Boffa MB, Johnston SM, Koschinsky ML. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation. Journal of Thrombosis and Haemostasis : Jth. 6: 2113-20. PMID 18983515 DOI: 10.1111/J.1538-7836.2008.03183.X |
0.415 |
|
| 2008 |
Cho T, Jung Y, Koschinsky ML. Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway. The Journal of Biological Chemistry. 283: 30503-12. PMID 18776185 DOI: 10.1074/jbc.M802648200 |
0.338 |
|
| 2008 |
Klein JH, Hegele RA, Hackam DG, Koschinsky ML, Huff MW, Spence JD. Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1851-6. PMID 18599799 DOI: 10.1161/Atvbaha.108.169292 |
0.314 |
|
| 2008 |
Staples J, Taylor P, Magil A, Frohlich J, Johnston SM, Koschinsky M, Chan-Yan C, Levin A. Progressive kidney disease in three sisters with elevated lipoprotein(a) Nephrology Dialysis Transplantation. 23: 1756-1759. PMID 18199694 DOI: 10.1093/Ndt/Gfm866 |
0.335 |
|
| 2008 |
Lin JHH, Boffa MB, Koschinsky ML. Regulation of Human Thrombin-Activable Fibrinolysis Inhibitor Gene Expression in Megakaryocyte-Like (Dami) and Monocyte/Macrphage- Like (THP-1) Cell Lines Blood. 112: 3078-3078. DOI: 10.1182/Blood.V112.11.3078.3078 |
0.377 |
|
| 2008 |
Garand M, Boffa MB, Koschinsky ML. Regulation of the Gene Encoding Human Thrombin-Activable Fibrinolysis Inhibitor by Female Sex Steroids Blood. 112: 3077-3077. DOI: 10.1182/Blood.V112.11.3077.3077 |
0.349 |
|
| 2007 |
Albers JJ, Koschinsky ML, Marcovina SM. Evidence mounts for a role of the kidney in lipoprotein(a) catabolism. Kidney International. 71: 961-2. PMID 17495935 DOI: 10.1038/Sj.Ki.5002240 |
0.352 |
|
| 2007 |
Boffa MB, Koschinsky ML. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles. Clinical Biochemistry. 40: 431-42. PMID 17331488 DOI: 10.1016/J.Clinbiochem.2006.10.020 |
0.321 |
|
| 2007 |
Chitayat S, Kanelis V, Koschinsky ML, Smith SP. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a). Biochemistry. 46: 1732-42. PMID 17263558 DOI: 10.1021/Bi061814G |
0.393 |
|
| 2006 |
Koschinsky ML. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovascular & Hematological Disorders Drug Targets. 6: 267-78. PMID 17378772 DOI: 10.2174/187152906779010764 |
0.425 |
|
| 2006 |
Anuurad E, Boffa MB, Koschinsky ML, Berglund L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clinics in Laboratory Medicine. 26: 751-72. PMID 17110238 DOI: 10.1016/J.Cll.2006.07.002 |
0.389 |
|
| 2006 |
Sotiriou SN, Orlova VV, Al-Fakhri N, Ihanus E, Economopoulou M, Isermann B, Bdeir K, Nawroth PP, Preissner KT, Gahmberg CG, Koschinsky ML, Chavakis T. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 559-61. PMID 16403785 DOI: 10.1096/Fj.05-4857Fje |
0.418 |
|
| 2005 |
Koschinsky ML. Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein. Current Atherosclerosis Reports. 7: 389-95. PMID 16105483 DOI: 10.1007/S11883-005-0052-Y |
0.447 |
|
| 2005 |
Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1704-10. PMID 15905467 DOI: 10.1161/01.Atv.0000170819.57945.03 |
0.379 |
|
| 2005 |
D'Angelo A, Geroldi D, Hancock MA, Valtulina V, Cornaglia AI, Spencer CA, Emanuele E, Calligaro A, Koschinsky ML, Speziale P, Visai L. The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. Biochimica Et Biophysica Acta. 1687: 1-10. PMID 15708348 DOI: 10.1016/J.Bbalip.2004.10.005 |
0.448 |
|
| 2005 |
Belczewski AR, Ho J, Taylor FB, Boffa MB, Jia Z, Koschinsky ML. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10. Biochemistry. 44: 555-64. PMID 15641780 DOI: 10.1021/Bi048156P |
0.712 |
|
| 2004 |
O'Neil CH, Boffa MB, Hancock MA, Pickering JG, Koschinsky ML. Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9. The Journal of Biological Chemistry. 279: 55187-95. PMID 15498766 DOI: 10.1074/Jbc.M409860200 |
0.331 |
|
| 2004 |
Hancock MA, Spencer CA, Koschinsky ML. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance. Biochemistry. 43: 12237-48. PMID 15379562 DOI: 10.1021/bi048756o |
0.323 |
|
| 2004 |
Becker L, Cook PM, Koschinsky ML. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation. Biochemistry. 43: 9978-88. PMID 15287725 DOI: 10.1021/bi049536d |
0.443 |
|
| 2004 |
Boffa MB, Marcovina SM, Koschinsky ML. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clinical Biochemistry. 37: 333-43. PMID 15087247 DOI: 10.1016/J.Clinbiochem.2003.12.007 |
0.436 |
|
| 2004 |
Koschinsky ML, Marcovina SM. Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Current Opinion in Lipidology. 15: 167-74. PMID 15017359 DOI: 10.1097/00041433-200404000-00009 |
0.358 |
|
| 2004 |
Becker L, Cook PM, Wright TG, Koschinsky ML. Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly. The Journal of Biological Chemistry. 279: 2679-88. PMID 14581473 DOI: 10.1074/Jbc.M309414200 |
0.475 |
|
| 2003 |
Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clinical Chemistry. 49: 1785-96. PMID 14578310 DOI: 10.1373/Clinchem.2003.023689 |
0.359 |
|
| 2003 |
Marcovina SM, Koschinsky ML. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Current Opinion in Lipidology. 14: 361-6. PMID 12865733 DOI: 10.1097/00041433-200308000-00004 |
0.376 |
|
| 2003 |
Belczewski AR, Laplaud PM, Chapman MJ, Marcovina SM, Koschinsky ML. Identification of a novel apolipoprotein(a)-related protein from the European hedgehog (Erinaceus europaeus). Dna Sequence : the Journal of Dna Sequencing and Mapping. 14: 15-23. PMID 12751328 DOI: 10.1080/1042517021000050642 |
0.686 |
|
| 2003 |
Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. The Journal of Biological Chemistry. 278: 23260-9. PMID 12697748 DOI: 10.1074/Jbc.M302780200 |
0.403 |
|
| 2003 |
Hill BC, Becker L, Anand V, Kusmierczyk A, Marcovina SM, Rahman MN, Gabel BR, Jia Z, Boffa MB, Koschinsky ML. A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation. Archives of Biochemistry and Biophysics. 412: 186-95. PMID 12667482 DOI: 10.1016/S0003-9861(03)00032-8 |
0.389 |
|
| 2003 |
Boffa MB, Hamill JD, Maret D, Brown D, Scott ML, Nesheim ME, Koschinsky ML. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 cells. The Journal of Biological Chemistry. 278: 9250-7. PMID 12645517 DOI: 10.1074/Jbc.M209588200 |
0.308 |
|
| 2002 |
Boffa MB, Hamill JD, Bastajian N, Dillon R, Nesheim ME, Koschinsky ML. A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitor. The Journal of Biological Chemistry. 277: 25329-36. PMID 12000765 DOI: 10.1074/Jbc.M203688200 |
0.41 |
|
| 2002 |
Rahman MN, Becker L, Petrounevitch V, Hill BC, Jia Z, Koschinsky ML. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10. Biochemistry. 41: 1149-55. PMID 11802713 DOI: 10.1021/Bi010964I |
0.433 |
|
| 2001 |
Gaubatz JW, Hoogeveen RC, Hoffman AS, Ghazzaly KG, Pownall HJ, Guevara J, Koschinsky ML, Morrisett JD. Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. Journal of Lipid Research. 42: 2058-68. PMID 11734579 |
0.31 |
|
| 2001 |
Becker L, Gabel BR, Spencer CA, Marcovina SM, Koschinsky ML. Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles. Clinical and Experimental Medicine. 1: 121-5. PMID 11699729 DOI: 10.1007/S10238-001-8022-3 |
0.408 |
|
| 2001 |
Weisel JW, Nagaswami C, Woodhead JL, Higazi AA, Cain WJ, Marcovina SM, Koschinsky ML, Cines DB, Bdeir K. The structure of lipoprotein(a) and ligand-induced conformational changes. Biochemistry. 40: 10424-35. PMID 11523984 DOI: 10.1021/Bi010556E |
0.353 |
|
| 2001 |
Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding. Protein Engineering. 14: 427-38. PMID 11477223 DOI: 10.1093/Protein/14.6.427 |
0.507 |
|
| 2001 |
Becker L, McLeod RS, Marcovina SM, Yao Z, Koschinsky ML. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a). The Journal of Biological Chemistry. 276: 36155-62. PMID 11473115 DOI: 10.1074/Jbc.M104789200 |
0.462 |
|
| 2001 |
Iliescu EA, Marcovina SM, Morton AR, Koschinsky ML. Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis. Nephron. 88: 168-9. PMID 11399921 DOI: 10.1159/000045979 |
0.33 |
|
| 2001 |
Ye Q, Rahman MN, Koschinsky ML, Jia Z. High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding. Protein Science : a Publication of the Protein Society. 10: 1124-9. PMID 11369850 DOI: 10.1110/Ps.01701 |
0.455 |
|
| 2000 |
Xia J, May LF, Koschinsky ML. Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity. Journal of Lipid Research. 41: 1578-84. PMID 11013299 |
0.31 |
|
| 2000 |
Sangrar W, Koschinsky ML. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 78: 519-25. PMID 11012092 |
0.337 |
|
| 2000 |
Haque NS, Zhang X, French DL, Li J, Poon M, Fallon JT, Gabel BR, Taubman MB, Koschinsky M, Harpel PC. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation. 102: 786-92. PMID 10942748 DOI: 10.1161/01.Cir.102.7.786 |
0.32 |
|
| 1999 |
Bdeir K, Cane W, Canziani G, Chaiken I, Weisel J, Koschinsky ML, Lawn RM, Bannerman PG, Sachais BS, Kuo A, Hancock MA, Tomaszewski J, Raghunath PN, Ganz T, Higazi AAR, et al. Defensin promotes the binding of lipoprotein(a) to vascular matrix Blood. 94: 2007-2019. PMID 10477730 |
0.338 |
|
| 1999 |
Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochemistry. 38: 6547-58. PMID 10350473 DOI: 10.1021/bi990229v |
0.325 |
|
| 1998 |
Rahman M, Jia Z, Gabel BR, Marcovina SM, Koschinsky ML. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100. Protein Engineering. 11: 1249-56. PMID 9930675 DOI: 10.1093/Protein/11.12.1249 |
0.474 |
|
| 1998 |
Marcovina SM, Koschinsky ML. Lipoprotein(a) as a risk factor for coronary artery disease. The American Journal of Cardiology. 82: 57U-66U; discussion . PMID 9915664 DOI: 10.1016/S0002-9149(98)00954-0 |
0.444 |
|
| 1998 |
Allen S, Khan S, Tam S, Koschinsky M, Taylor P, Yacoub M. Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity The Faseb Journal. 12: 1765-1776. PMID 9837867 DOI: 10.1096/Fasebj.12.15.1765 |
0.373 |
|
| 1998 |
Gabel BR, McLeod RS, Yao Z, Koschinsky ML. Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a). Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1738-44. PMID 9812912 DOI: 10.1161/01.Atv.18.11.1738 |
0.528 |
|
| 1998 |
Rand ML, Sangrar W, Hancock MA, Taylor DM, Marcovina SM, Packham MA, Koschinsky ML. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1393-9. PMID 9743227 DOI: 10.1161/01.Atv.18.9.1393 |
0.33 |
|
| 1998 |
Gabel BR, Koschinsky ML. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Biochemistry. 37: 7892-8. PMID 9601051 DOI: 10.1021/bi973186w |
0.406 |
|
| 1997 |
Koschinsky ML, Marcovina SM, May LF, Gabel BR. Analysis of the mechanism of lipoprotein(a) assembly. Clinical Genetics. 52: 338-46. PMID 9520124 DOI: 10.1111/J.1399-0004.1997.Tb04351.X |
0.528 |
|
| 1997 |
Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar W, Xia J, Büller HR, ten Cate JW. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. Circulation. 96: 1612-5. PMID 9315555 |
0.368 |
|
| 1997 |
Sangrar W, Gabel BR, Boffa MB, Walker JB, Hancock MA, Marcovina SM, Horrevoets AJ, Nesheim ME, Koschinsky ML. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. Biochemistry. 36: 10353-63. PMID 9265615 DOI: 10.1021/Bi962433D |
0.485 |
|
| 1997 |
Koschinsky ML, Marcovina SM. Lipoprotein(a): structural implications for pathophysiology. International Journal of Clinical & Laboratory Research. 27: 14-23. PMID 9144023 DOI: 10.1007/Bf02827238 |
0.399 |
|
| 1996 |
Gabel BR, May LF, Marcovina SM, Koschinsky ML. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 16: 1559-67. PMID 8977462 |
0.333 |
|
| 1996 |
Keesler GA, Gabel BR, Devlin CM, Koschinsky ML, Tabas I. The binding activity of the macrophage lipoprotein(a)/apolipoprotein(a) receptor is induced by cholesterol via a post-translational mechanism and recognizes distinct kringle domains on apolipoprotein(a). The Journal of Biological Chemistry. 271: 32096-104. PMID 8943262 DOI: 10.1074/Jbc.271.50.32096 |
0.467 |
|
| 1996 |
Belczewski AR, Laplaud PM, Chapman MJ, Koschinsky ML. The complete cDNA sequence encoding plasminogen from the European hedgehog (Erinaceus europaeus). Gene. 171: 271-4. PMID 8666285 DOI: 10.1016/0378-1119(96)00011-X |
0.678 |
|
| 1995 |
Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clinical Chemistry. 41: 246-55. PMID 7533064 |
0.315 |
|
| 1994 |
Anglés-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator. Chemistry and Physics of Lipids. 67: 369-80. PMID 8187237 DOI: 10.1016/0009-3084(94)90159-7 |
0.487 |
|
| 1994 |
Sangrar W, Marcovina SM, Koschinsky ML. Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. Protein Engineering. 7: 723-31. PMID 8073042 DOI: 10.1093/Protein/7.5.723 |
0.405 |
|
| 1994 |
van der Hoek YY, Kastelein JJ, Koschinsky ML. Analysis of structure--function relationships in human apolipoprotein(a). Canadian Journal of Physiology and Pharmacology. 72: 304-10. PMID 8069777 DOI: 10.1139/Y94-046 |
0.524 |
|
| 1994 |
Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML. Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation. Febs Letters. 350: 77-81. PMID 8062928 DOI: 10.1016/0014-5793(94)00737-3 |
0.448 |
|
| 1994 |
van der Hoek YY, Sangrar W, Côté GP, Kastelein JJ, Koschinsky ML. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. Arteriosclerosis and Thrombosis : a Journal of Vascular Biology / American Heart Association. 14: 1792-8. PMID 7947605 DOI: 10.1161/01.Atv.14.11.1792 |
0.467 |
|
| 1993 |
van der Hoek YY, Wittekoek ME, Beisiegel U, Kastelein JJ, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Human Molecular Genetics. 2: 361-6. PMID 8389224 DOI: 10.1093/Hmg/2.4.361 |
0.511 |
|
| 1992 |
Rouy D, Koschinsky ML, Fleury V, Chapman J, Anglés-Cano E. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry. 31: 6333-9. PMID 1627572 DOI: 10.1021/Bi00142A024 |
0.492 |
|
| 1992 |
Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). The Journal of Biological Chemistry. 267: 24369-74. PMID 1280258 |
0.326 |
|
| 1991 |
Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry. 30: 5044-51. PMID 2036372 DOI: 10.1021/bi00234a029 |
0.334 |
|
| 1990 |
Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry. 29: 640-4. PMID 2140053 DOI: 10.1021/bi00455a007 |
0.304 |
|
| 1987 |
Koschinsky ML, Chow BK, Schwartz J, Hamerton JL, MacGillivray RT. Isolation and characterization of a processed gene for human ceruloplasmin. Biochemistry. 26: 7760-7. PMID 3427102 DOI: 10.1021/Bi00398A034 |
0.348 |
|
| 1986 |
Koschinsky ML, Funk WD, van Oost BA, MacGillivray RT. Complete cDNA sequence of human preceruloplasmin. Proceedings of the National Academy of Sciences of the United States of America. 83: 5086-90. PMID 2873574 DOI: 10.1073/Pnas.83.14.5086 |
0.341 |
|
| Show low-probability matches. |